dbSNP Short Genetic Variations
Welcome to the Reference SNP (rs) Report
All alleles are reported in the Forward orientation. Click on the Variant Details tab for details on Genomic Placement, Gene, and Amino Acid changes. HGVS names are in the HGVS tab.
Reference SNP (rs) Report
This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.
rs6189
Current Build 156
Released September 21, 2022
- Organism
- Homo sapiens
- Position
-
chr5:143400774 (GRCh38.p14) Help
The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.
- Alleles
- C>A / C>T
- Variation Type
- SNV Single Nucleotide Variation
- Frequency
-
T=0.014889 (3941/264690, TOPMED)T=0.023647 (4114/173978, ALFA)T=0.016848 (2363/140250, GnomAD) (+ 20 more)
- Clinical Significance
- Reported in ClinVar
- Gene : Consequence
- NR3C1 : Missense Variant
- Publications
- 47 citations
- Genomic View
- See rs on genome
ALFA Allele Frequency
The ALFA project provide aggregate allele frequency from dbGaP. More information is available on the project page including descriptions, data access, and terms of use.
Population | Group | Sample Size | Ref Allele | Alt Allele | Ref HMOZ | Alt HMOZ | HTRZ | HWEP |
---|---|---|---|---|---|---|---|---|
Total | Global | 190274 | C=0.976881 | T=0.023119 | 0.954487 | 0.000725 | 0.044788 | 4 |
European | Sub | 158750 | C=0.974369 | T=0.025631 | 0.949543 | 0.000806 | 0.04965 | 2 |
African | Sub | 13672 | C=0.99532 | T=0.00468 | 0.990638 | 0.0 | 0.009362 | 0 |
African Others | Sub | 484 | C=1.000 | T=0.000 | 1.0 | 0.0 | 0.0 | N/A |
African American | Sub | 13188 | C=0.99515 | T=0.00485 | 0.990294 | 0.0 | 0.009706 | 0 |
Asian | Sub | 3426 | C=0.9997 | T=0.0003 | 0.999416 | 0.0 | 0.000584 | 0 |
East Asian | Sub | 2768 | C=1.0000 | T=0.0000 | 1.0 | 0.0 | 0.0 | N/A |
Other Asian | Sub | 658 | C=0.998 | T=0.002 | 0.99696 | 0.0 | 0.00304 | 0 |
Latin American 1 | Sub | 812 | C=0.991 | T=0.009 | 0.982759 | 0.0 | 0.017241 | 0 |
Latin American 2 | Sub | 1036 | C=0.9913 | T=0.0087 | 0.982625 | 0.0 | 0.017375 | 0 |
South Asian | Sub | 298 | C=0.977 | T=0.023 | 0.95302 | 0.0 | 0.04698 | 0 |
Other | Sub | 12280 | C=0.98029 | T=0.01971 | 0.961401 | 0.000814 | 0.037785 | 2 |
Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").
DownloadStudy | Population | Group | Sample Size | Ref Allele | Alt Allele |
---|---|---|---|---|---|
TopMed | Global | Study-wide | 264690 | C=0.985111 | T=0.014889 |
Allele Frequency Aggregator | Total | Global | 173978 | C=0.976353 | T=0.023647 |
Allele Frequency Aggregator | European | Sub | 148724 | C=0.974221 | T=0.025779 |
Allele Frequency Aggregator | Other | Sub | 10844 | C=0.98008 | T=0.01992 |
Allele Frequency Aggregator | African | Sub | 8838 | C=0.9955 | T=0.0045 |
Allele Frequency Aggregator | Asian | Sub | 3426 | C=0.9997 | T=0.0003 |
Allele Frequency Aggregator | Latin American 2 | Sub | 1036 | C=0.9913 | T=0.0087 |
Allele Frequency Aggregator | Latin American 1 | Sub | 812 | C=0.991 | T=0.009 |
Allele Frequency Aggregator | South Asian | Sub | 298 | C=0.977 | T=0.023 |
gnomAD - Genomes | Global | Study-wide | 140250 | C=0.983152 | T=0.016848 |
gnomAD - Genomes | European | Sub | 75930 | C=0.97379 | T=0.02621 |
gnomAD - Genomes | African | Sub | 42046 | C=0.99510 | T=0.00490 |
gnomAD - Genomes | American | Sub | 13668 | C=0.99356 | T=0.00644 |
gnomAD - Genomes | Ashkenazi Jewish | Sub | 3322 | C=0.9822 | T=0.0178 |
gnomAD - Genomes | East Asian | Sub | 3134 | C=1.0000 | T=0.0000 |
gnomAD - Genomes | Other | Sub | 2150 | C=0.9907 | T=0.0093 |
ExAC | Global | Study-wide | 121268 | C=0.982163 | T=0.017837 |
ExAC | Europe | Sub | 73270 | C=0.97565 | T=0.02435 |
ExAC | Asian | Sub | 25140 | C=0.99025 | T=0.00975 |
ExAC | American | Sub | 11560 | C=0.99412 | T=0.00588 |
ExAC | African | Sub | 10392 | C=0.99509 | T=0.00491 |
ExAC | Other | Sub | 906 | C=0.983 | T=0.017 |
The PAGE Study | Global | Study-wide | 78698 | C=0.99414 | T=0.00586 |
The PAGE Study | AfricanAmerican | Sub | 32516 | C=0.99502 | T=0.00498 |
The PAGE Study | Mexican | Sub | 10808 | C=0.99288 | T=0.00712 |
The PAGE Study | Asian | Sub | 8318 | C=0.9998 | T=0.0002 |
The PAGE Study | PuertoRican | Sub | 7918 | C=0.9941 | T=0.0059 |
The PAGE Study | NativeHawaiian | Sub | 4534 | C=0.9938 | T=0.0062 |
The PAGE Study | Cuban | Sub | 4230 | C=0.9905 | T=0.0095 |
The PAGE Study | Dominican | Sub | 3828 | C=0.9919 | T=0.0081 |
The PAGE Study | CentralAmerican | Sub | 2450 | C=0.9927 | T=0.0073 |
The PAGE Study | SouthAmerican | Sub | 1982 | C=0.9934 | T=0.0066 |
The PAGE Study | NativeAmerican | Sub | 1258 | C=0.9793 | T=0.0207 |
The PAGE Study | SouthAsian | Sub | 856 | C=0.980 | T=0.020 |
GO Exome Sequencing Project | Global | Study-wide | 13006 | C=0.97909 | T=0.02091 |
GO Exome Sequencing Project | European American | Sub | 8600 | C=0.9707 | T=0.0293 |
GO Exome Sequencing Project | African American | Sub | 4406 | C=0.9955 | T=0.0045 |
1000Genomes_30x | Global | Study-wide | 6404 | C=0.9903 | T=0.0097 |
1000Genomes_30x | African | Sub | 1786 | C=1.0000 | T=0.0000 |
1000Genomes_30x | Europe | Sub | 1266 | C=0.9724 | T=0.0276 |
1000Genomes_30x | South Asian | Sub | 1202 | C=0.9842 | T=0.0158 |
1000Genomes_30x | East Asian | Sub | 1170 | C=0.9991 | T=0.0009 |
1000Genomes_30x | American | Sub | 980 | C=0.993 | T=0.007 |
1000Genomes | Global | Study-wide | 5008 | C=0.9894 | T=0.0106 |
1000Genomes | African | Sub | 1322 | C=1.0000 | T=0.0000 |
1000Genomes | East Asian | Sub | 1008 | C=0.9990 | T=0.0010 |
1000Genomes | Europe | Sub | 1006 | C=0.9702 | T=0.0298 |
1000Genomes | South Asian | Sub | 978 | C=0.982 | T=0.018 |
1000Genomes | American | Sub | 694 | C=0.994 | T=0.006 |
Genetic variation in the Estonian population | Estonian | Study-wide | 4480 | C=0.9777 | T=0.0223 |
The Avon Longitudinal Study of Parents and Children | PARENT AND CHILD COHORT | Study-wide | 3854 | C=0.9696 | T=0.0304 |
UK 10K study - Twins | TWIN COHORT | Study-wide | 3708 | C=0.9730 | T=0.0270 |
KOREAN population from KRGDB | KOREAN | Study-wide | 2922 | C=1.0000 | T=0.0000 |
Genome-wide autozygosity in Daghestan | Global | Study-wide | 1124 | C=0.9742 | T=0.0258 |
Genome-wide autozygosity in Daghestan | Daghestan | Sub | 624 | C=0.968 | T=0.032 |
Genome-wide autozygosity in Daghestan | Near_East | Sub | 144 | C=1.000 | T=0.000 |
Genome-wide autozygosity in Daghestan | Central Asia | Sub | 120 | C=1.000 | T=0.000 |
Genome-wide autozygosity in Daghestan | Europe | Sub | 106 | C=0.991 | T=0.009 |
Genome-wide autozygosity in Daghestan | South Asian | Sub | 94 | C=0.91 | T=0.09 |
Genome-wide autozygosity in Daghestan | Caucasus | Sub | 36 | C=1.00 | T=0.00 |
Genome of the Netherlands Release 5 | Genome of the Netherlands | Study-wide | 998 | C=0.973 | T=0.027 |
Northern Sweden | ACPOP | Study-wide | 600 | C=0.972 | T=0.028 |
Medical Genome Project healthy controls from Spanish population | Spanish controls | Study-wide | 534 | C=0.987 | T=0.013 |
PharmGKB Aggregated | Global | Study-wide | 526 | C=0.990 | T=0.010 |
PharmGKB Aggregated | PA162048949 | Sub | 526 | C=0.990 | T=0.010 |
FINRISK | Finnish from FINRISK project | Study-wide | 304 | C=0.977 | T=0.023 |
The Danish reference pan genome | Danish | Study-wide | 40 | C=0.97 | T=0.03 |
SGDP_PRJ | Global | Study-wide | 20 | C=0.50 | T=0.50 |
Siberian | Global | Study-wide | 4 | C=0.5 | T=0.5 |
Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.
Sequence name | Change |
---|---|
GRCh38.p14 chr 5 | NC_000005.10:g.143400774C>A |
GRCh38.p14 chr 5 | NC_000005.10:g.143400774C>T |
GRCh37.p13 chr 5 | NC_000005.9:g.142780339C>A |
GRCh37.p13 chr 5 | NC_000005.9:g.142780339C>T |
NR3C1 RefSeqGene | NG_009062.1:g.39739G>T |
NR3C1 RefSeqGene | NG_009062.1:g.39739G>A |
Molecule type | Change | Amino acid[Codon] | SO Term |
---|---|---|---|
NR3C1 transcript variant 1 | NM_001204258.2:c.-13= | N/A | 5 Prime UTR Variant |
NR3C1 transcript variant 1 | NM_001204259.2:c.-190= | N/A | 5 Prime UTR Variant |
NR3C1 transcript variant 1 | NM_001204260.2:c.-202= | N/A | 5 Prime UTR Variant |
NR3C1 transcript variant 1 | NM_001204261.2:c.-226= | N/A | 5 Prime UTR Variant |
NR3C1 transcript variant 1 | NM_001204262.2:c.-880= | N/A | 5 Prime UTR Variant |
NR3C1 transcript variant 1 | NM_001204263.2:c.-925= | N/A | 5 Prime UTR Variant |
NR3C1 transcript variant 1 | NM_001204264.2:c.-940= | N/A | 5 Prime UTR Variant |
NR3C1 transcript variant 2 | NM_001018074.1:c.66G>T | E [GAG] > D [GAT] | Coding Sequence Variant |
glucocorticoid receptor isoform alpha | NP_001018084.1:p.Glu22Asp | E (Glu) > D (Asp) | Missense Variant |
NR3C1 transcript variant 2 | NM_001018074.1:c.66G>A | E [GAG] > E [GAA] | Coding Sequence Variant |
glucocorticoid receptor isoform alpha | NP_001018084.1:p.Glu22= | E (Glu) > E (Glu) | Synonymous Variant |
NR3C1 transcript variant 3 | NM_001018075.1:c.66G>T | E [GAG] > D [GAT] | Coding Sequence Variant |
glucocorticoid receptor isoform alpha | NP_001018085.1:p.Glu22Asp | E (Glu) > D (Asp) | Missense Variant |
NR3C1 transcript variant 3 | NM_001018075.1:c.66G>A | E [GAG] > E [GAA] | Coding Sequence Variant |
glucocorticoid receptor isoform alpha | NP_001018085.1:p.Glu22= | E (Glu) > E (Glu) | Synonymous Variant |
NR3C1 transcript variant 5 | NM_001018077.1:c.66G>T | E [GAG] > D [GAT] | Coding Sequence Variant |
glucocorticoid receptor isoform alpha | NP_001018087.1:p.Glu22Asp | E (Glu) > D (Asp) | Missense Variant |
NR3C1 transcript variant 5 | NM_001018077.1:c.66G>A | E [GAG] > E [GAA] | Coding Sequence Variant |
glucocorticoid receptor isoform alpha | NP_001018087.1:p.Glu22= | E (Glu) > E (Glu) | Synonymous Variant |
NR3C1 transcript variant 14 | NM_001364185.1:c.66G>T | E [GAG] > D [GAT] | Coding Sequence Variant |
glucocorticoid receptor isoform gamma | NP_001351114.1:p.Glu22Asp | E (Glu) > D (Asp) | Missense Variant |
NR3C1 transcript variant 14 | NM_001364185.1:c.66G>A | E [GAG] > E [GAA] | Coding Sequence Variant |
glucocorticoid receptor isoform gamma | NP_001351114.1:p.Glu22= | E (Glu) > E (Glu) | Synonymous Variant |
NR3C1 transcript variant 11 | NM_001364182.1:c.66G>T | E [GAG] > D [GAT] | Coding Sequence Variant |
glucocorticoid receptor isoform alpha | NP_001351111.1:p.Glu22Asp | E (Glu) > D (Asp) | Missense Variant |
NR3C1 transcript variant 11 | NM_001364182.1:c.66G>A | E [GAG] > E [GAA] | Coding Sequence Variant |
glucocorticoid receptor isoform alpha | NP_001351111.1:p.Glu22= | E (Glu) > E (Glu) | Synonymous Variant |
NR3C1 transcript variant 1 | NM_000176.3:c.66G>T | E [GAG] > D [GAT] | Coding Sequence Variant |
glucocorticoid receptor isoform alpha | NP_000167.1:p.Glu22Asp | E (Glu) > D (Asp) | Missense Variant |
NR3C1 transcript variant 1 | NM_000176.3:c.66G>A | E [GAG] > E [GAA] | Coding Sequence Variant |
glucocorticoid receptor isoform alpha | NP_000167.1:p.Glu22= | E (Glu) > E (Glu) | Synonymous Variant |
NR3C1 transcript variant 9 | NM_001364180.2:c.66G>T | E [GAG] > D [GAT] | Coding Sequence Variant |
glucocorticoid receptor isoform alpha | NP_001351109.1:p.Glu22Asp | E (Glu) > D (Asp) | Missense Variant |
NR3C1 transcript variant 9 | NM_001364180.2:c.66G>A | E [GAG] > E [GAA] | Coding Sequence Variant |
glucocorticoid receptor isoform alpha | NP_001351109.1:p.Glu22= | E (Glu) > E (Glu) | Synonymous Variant |
NR3C1 transcript variant 12 | NM_001364183.2:c.66G>T | E [GAG] > D [GAT] | Coding Sequence Variant |
glucocorticoid receptor isoform gamma | NP_001351112.1:p.Glu22Asp | E (Glu) > D (Asp) | Missense Variant |
NR3C1 transcript variant 12 | NM_001364183.2:c.66G>A | E [GAG] > E [GAA] | Coding Sequence Variant |
glucocorticoid receptor isoform gamma | NP_001351112.1:p.Glu22= | E (Glu) > E (Glu) | Synonymous Variant |
NR3C1 transcript variant 10 | NM_001364181.2:c.66G>T | E [GAG] > D [GAT] | Coding Sequence Variant |
glucocorticoid receptor isoform alpha | NP_001351110.1:p.Glu22Asp | E (Glu) > D (Asp) | Missense Variant |
NR3C1 transcript variant 10 | NM_001364181.2:c.66G>A | E [GAG] > E [GAA] | Coding Sequence Variant |
glucocorticoid receptor isoform alpha | NP_001351110.1:p.Glu22= | E (Glu) > E (Glu) | Synonymous Variant |
NR3C1 transcript variant 13 | NM_001364184.2:c.66G>T | E [GAG] > D [GAT] | Coding Sequence Variant |
glucocorticoid receptor isoform gamma | NP_001351113.1:p.Glu22Asp | E (Glu) > D (Asp) | Missense Variant |
NR3C1 transcript variant 13 | NM_001364184.2:c.66G>A | E [GAG] > E [GAA] | Coding Sequence Variant |
glucocorticoid receptor isoform gamma | NP_001351113.1:p.Glu22= | E (Glu) > E (Glu) | Synonymous Variant |
NR3C1 transcript variant 4 | NM_001018076.2:c.66G>T | E [GAG] > D [GAT] | Coding Sequence Variant |
glucocorticoid receptor isoform alpha | NP_001018086.1:p.Glu22Asp | E (Glu) > D (Asp) | Missense Variant |
NR3C1 transcript variant 4 | NM_001018076.2:c.66G>A | E [GAG] > E [GAA] | Coding Sequence Variant |
glucocorticoid receptor isoform alpha | NP_001018086.1:p.Glu22= | E (Glu) > E (Glu) | Synonymous Variant |
NR3C1 transcript variant 6 | NM_001020825.2:c.66G>T | E [GAG] > D [GAT] | Coding Sequence Variant |
glucocorticoid receptor isoform beta | NP_001018661.1:p.Glu22Asp | E (Glu) > D (Asp) | Missense Variant |
NR3C1 transcript variant 6 | NM_001020825.2:c.66G>A | E [GAG] > E [GAA] | Coding Sequence Variant |
glucocorticoid receptor isoform beta | NP_001018661.1:p.Glu22= | E (Glu) > E (Glu) | Synonymous Variant |
NR3C1 transcript variant 7 | NM_001024094.2:c.66G>T | E [GAG] > D [GAT] | Coding Sequence Variant |
glucocorticoid receptor isoform gamma | NP_001019265.1:p.Glu22Asp | E (Glu) > D (Asp) | Missense Variant |
NR3C1 transcript variant 7 | NM_001024094.2:c.66G>A | E [GAG] > E [GAA] | Coding Sequence Variant |
glucocorticoid receptor isoform gamma | NP_001019265.1:p.Glu22= | E (Glu) > E (Glu) | Synonymous Variant |
NR3C1 transcript variant 8 | NM_001204265.2:c.66G>T | E [GAG] > D [GAT] | Coding Sequence Variant |
glucocorticoid receptor isoform GR-P | NP_001191194.1:p.Glu22Asp | E (Glu) > D (Asp) | Missense Variant |
NR3C1 transcript variant 8 | NM_001204265.2:c.66G>A | E [GAG] > E [GAA] | Coding Sequence Variant |
glucocorticoid receptor isoform GR-P | NP_001191194.1:p.Glu22= | E (Glu) > E (Glu) | Synonymous Variant |
NR3C1 transcript variant 15 | NR_157096.2:n. | N/A | Intron Variant |
Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.
ClinVar Accession | Disease Names | Clinical Significance |
---|---|---|
RCV000017536.30 | Glucocorticoid resistance, relative | Pathogenic |
RCV000360936.4 | Glucocorticoid resistance | Benign-Likely-Benign |
RCV002055861.3 | not provided | Benign |
Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".
Placement | C= | A | T |
---|---|---|---|
GRCh38.p14 chr 5 | NC_000005.10:g.143400774= | NC_000005.10:g.143400774C>A | NC_000005.10:g.143400774C>T |
GRCh37.p13 chr 5 | NC_000005.9:g.142780339= | NC_000005.9:g.142780339C>A | NC_000005.9:g.142780339C>T |
NR3C1 RefSeqGene | NG_009062.1:g.39739= | NG_009062.1:g.39739G>T | NG_009062.1:g.39739G>A |
NR3C1 transcript variant 1 | NM_000176.3:c.66= | NM_000176.3:c.66G>T | NM_000176.3:c.66G>A |
NR3C1 transcript variant 1 | NM_000176.2:c.66= | NM_000176.2:c.66G>T | NM_000176.2:c.66G>A |
NR3C1 transcript variant 7 | NM_001024094.2:c.66= | NM_001024094.2:c.66G>T | NM_001024094.2:c.66G>A |
NR3C1 transcript variant 7 | NM_001024094.1:c.66= | NM_001024094.1:c.66G>T | NM_001024094.1:c.66G>A |
NR3C1 transcript variant 1 | NM_001204264.2:c.-940= | NM_001204264.2:c.-940G>T | NM_001204264.2:c.-940G>A |
NR3C1 transcript variant 1 | NM_001204264.1:c.-940= | NM_001204264.1:c.-940G>T | NM_001204264.1:c.-940G>A |
NR3C1 transcript variant 1 | NM_001204263.2:c.-925= | NM_001204263.2:c.-925G>T | NM_001204263.2:c.-925G>A |
NR3C1 transcript variant 1 | NM_001204263.1:c.-925= | NM_001204263.1:c.-925G>T | NM_001204263.1:c.-925G>A |
NR3C1 transcript variant 1 | NM_001204262.2:c.-880= | NM_001204262.2:c.-880G>T | NM_001204262.2:c.-880G>A |
NR3C1 transcript variant 1 | NM_001204262.1:c.-880= | NM_001204262.1:c.-880G>T | NM_001204262.1:c.-880G>A |
NR3C1 transcript variant 1 | NM_001204261.2:c.-226= | NM_001204261.2:c.-226G>T | NM_001204261.2:c.-226G>A |
NR3C1 transcript variant 1 | NM_001204261.1:c.-226= | NM_001204261.1:c.-226G>T | NM_001204261.1:c.-226G>A |
NR3C1 transcript variant 1 | NM_001204260.2:c.-202= | NM_001204260.2:c.-202G>T | NM_001204260.2:c.-202G>A |
NR3C1 transcript variant 1 | NM_001204260.1:c.-202= | NM_001204260.1:c.-202G>T | NM_001204260.1:c.-202G>A |
NR3C1 transcript variant 1 | NM_001204259.2:c.-190= | NM_001204259.2:c.-190G>T | NM_001204259.2:c.-190G>A |
NR3C1 transcript variant 1 | NM_001204259.1:c.-190= | NM_001204259.1:c.-190G>T | NM_001204259.1:c.-190G>A |
NR3C1 transcript variant 1 | NM_001204258.2:c.-13= | NM_001204258.2:c.-13G>T | NM_001204258.2:c.-13G>A |
NR3C1 transcript variant 1 | NM_001204258.1:c.-13= | NM_001204258.1:c.-13G>T | NM_001204258.1:c.-13G>A |
NR3C1 transcript variant 12 | NM_001364183.2:c.66= | NM_001364183.2:c.66G>T | NM_001364183.2:c.66G>A |
NR3C1 transcript variant 12 | NM_001364183.1:c.66= | NM_001364183.1:c.66G>T | NM_001364183.1:c.66G>A |
NR3C1 transcript variant 10 | NM_001364181.2:c.66= | NM_001364181.2:c.66G>T | NM_001364181.2:c.66G>A |
NR3C1 transcript variant 10 | NM_001364181.1:c.66= | NM_001364181.1:c.66G>T | NM_001364181.1:c.66G>A |
NR3C1 transcript variant 9 | NM_001364180.2:c.66= | NM_001364180.2:c.66G>T | NM_001364180.2:c.66G>A |
NR3C1 transcript variant 9 | NM_001364180.1:c.66= | NM_001364180.1:c.66G>T | NM_001364180.1:c.66G>A |
NR3C1 transcript variant 13 | NM_001364184.2:c.66= | NM_001364184.2:c.66G>T | NM_001364184.2:c.66G>A |
NR3C1 transcript variant 13 | NM_001364184.1:c.66= | NM_001364184.1:c.66G>T | NM_001364184.1:c.66G>A |
NR3C1 transcript variant 4 | NM_001018076.2:c.66= | NM_001018076.2:c.66G>T | NM_001018076.2:c.66G>A |
NR3C1 transcript variant 4 | NM_001018076.1:c.66= | NM_001018076.1:c.66G>T | NM_001018076.1:c.66G>A |
NR3C1 transcript variant 6 | NM_001020825.2:c.66= | NM_001020825.2:c.66G>T | NM_001020825.2:c.66G>A |
NR3C1 transcript variant 6 | NM_001020825.1:c.66= | NM_001020825.1:c.66G>T | NM_001020825.1:c.66G>A |
NR3C1 transcript variant 8 | NM_001204265.2:c.66= | NM_001204265.2:c.66G>T | NM_001204265.2:c.66G>A |
NR3C1 transcript variant 8 | NM_001204265.1:c.66= | NM_001204265.1:c.66G>T | NM_001204265.1:c.66G>A |
NR3C1 transcript variant 5 | NM_001018077.1:c.66= | NM_001018077.1:c.66G>T | NM_001018077.1:c.66G>A |
NR3C1 transcript variant 14 | NM_001364185.1:c.66= | NM_001364185.1:c.66G>T | NM_001364185.1:c.66G>A |
NR3C1 transcript variant 11 | NM_001364182.1:c.66= | NM_001364182.1:c.66G>T | NM_001364182.1:c.66G>A |
NR3C1 transcript variant 2 | NM_001018074.1:c.66= | NM_001018074.1:c.66G>T | NM_001018074.1:c.66G>A |
NR3C1 transcript variant 3 | NM_001018075.1:c.66= | NM_001018075.1:c.66G>T | NM_001018075.1:c.66G>A |
glucocorticoid receptor isoform alpha | NP_000167.1:p.Glu22= | NP_000167.1:p.Glu22Asp | NP_000167.1:p.Glu22= |
glucocorticoid receptor isoform gamma | NP_001019265.1:p.Glu22= | NP_001019265.1:p.Glu22Asp | NP_001019265.1:p.Glu22= |
glucocorticoid receptor isoform gamma | NP_001351112.1:p.Glu22= | NP_001351112.1:p.Glu22Asp | NP_001351112.1:p.Glu22= |
glucocorticoid receptor isoform alpha | NP_001351110.1:p.Glu22= | NP_001351110.1:p.Glu22Asp | NP_001351110.1:p.Glu22= |
glucocorticoid receptor isoform alpha | NP_001351109.1:p.Glu22= | NP_001351109.1:p.Glu22Asp | NP_001351109.1:p.Glu22= |
glucocorticoid receptor isoform gamma | NP_001351113.1:p.Glu22= | NP_001351113.1:p.Glu22Asp | NP_001351113.1:p.Glu22= |
glucocorticoid receptor isoform alpha | NP_001018086.1:p.Glu22= | NP_001018086.1:p.Glu22Asp | NP_001018086.1:p.Glu22= |
glucocorticoid receptor isoform beta | NP_001018661.1:p.Glu22= | NP_001018661.1:p.Glu22Asp | NP_001018661.1:p.Glu22= |
glucocorticoid receptor isoform GR-P | NP_001191194.1:p.Glu22= | NP_001191194.1:p.Glu22Asp | NP_001191194.1:p.Glu22= |
glucocorticoid receptor isoform alpha | NP_001018087.1:p.Glu22= | NP_001018087.1:p.Glu22Asp | NP_001018087.1:p.Glu22= |
glucocorticoid receptor isoform gamma | NP_001351114.1:p.Glu22= | NP_001351114.1:p.Glu22Asp | NP_001351114.1:p.Glu22= |
glucocorticoid receptor isoform alpha | NP_001351111.1:p.Glu22= | NP_001351111.1:p.Glu22Asp | NP_001351111.1:p.Glu22= |
glucocorticoid receptor isoform alpha | NP_001018084.1:p.Glu22= | NP_001018084.1:p.Glu22Asp | NP_001018084.1:p.Glu22= |
glucocorticoid receptor isoform alpha | NP_001018085.1:p.Glu22= | NP_001018085.1:p.Glu22Asp | NP_001018085.1:p.Glu22= |
Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.
No | Submitter | Submission ID | Date (Build) |
---|---|---|---|
1 | WIAF-CSNP | ss7811 | Sep 19, 2000 (52) |
2 | EGP_SNPS | ss14865728 | Dec 05, 2003 (119) |
3 | ILLUMINA | ss75137989 | Dec 06, 2007 (129) |
4 | RSG_UW | ss86211774 | Mar 23, 2008 (129) |
5 | UUGC | ss102664198 | Feb 05, 2009 (130) |
6 | PHARMGKB_PPII | ss105110606 | Feb 05, 2009 (130) |
7 | 1000GENOMES | ss109472596 | Jan 24, 2009 (130) |
8 | KRIBB_YJKIM | ss119337796 | Dec 01, 2009 (131) |
9 | ILLUMINA | ss173989801 | Jul 04, 2010 (132) |
10 | 1000GENOMES | ss233177998 | Jul 14, 2010 (132) |
11 | NHLBI-ESP | ss342192853 | May 09, 2011 (134) |
12 | ILLUMINA | ss483735877 | May 04, 2012 (137) |
13 | ILLUMINA | ss484950594 | May 04, 2012 (137) |
14 | 1000GENOMES | ss490912774 | May 04, 2012 (137) |
15 | CLINSEQ_SNP | ss491875137 | May 04, 2012 (137) |
16 | ILLUMINA | ss535936231 | Sep 08, 2015 (146) |
17 | ILLUMINA | ss779515274 | Sep 08, 2015 (146) |
18 | ILLUMINA | ss782311487 | Sep 08, 2015 (146) |
19 | ILLUMINA | ss834985687 | Sep 08, 2015 (146) |
20 | EVA-GONL | ss982205738 | Aug 21, 2014 (142) |
21 | 1000GENOMES | ss1317539291 | Aug 21, 2014 (142) |
22 | HAMMER_LAB | ss1397429719 | Sep 08, 2015 (146) |
23 | OMIM-CURATED-RECORDS | ss1505810956 | Dec 08, 2014 (142) |
24 | EVA_GENOME_DK | ss1581380988 | Apr 01, 2015 (144) |
25 | EVA_FINRISK | ss1584041667 | Apr 01, 2015 (144) |
26 | EVA_DECODE | ss1591735738 | Apr 01, 2015 (144) |
27 | EVA_UK10K_ALSPAC | ss1614185168 | Apr 01, 2015 (144) |
28 | EVA_UK10K_TWINSUK | ss1657179201 | Apr 01, 2015 (144) |
29 | EVA_EXAC | ss1688018862 | Apr 01, 2015 (144) |
30 | EVA_MGP | ss1711100968 | Apr 01, 2015 (144) |
31 | ILLUMINA | ss1946158045 | Feb 12, 2016 (147) |
32 | ILLUMINA | ss1958830249 | Feb 12, 2016 (147) |
33 | GENOMED | ss1970224803 | Jul 19, 2016 (147) |
34 | JJLAB | ss2023336077 | Sep 14, 2016 (149) |
35 | USC_VALOUEV | ss2151494857 | Dec 20, 2016 (150) |
36 | HUMAN_LONGEVITY | ss2278834823 | Dec 20, 2016 (150) |
37 | ILLUMINA | ss2634349964 | Nov 08, 2017 (151) |
38 | ILLUMINA | ss2634349965 | Nov 08, 2017 (151) |
39 | ILLUMINA | ss2711050776 | Nov 08, 2017 (151) |
40 | GNOMAD | ss2735324419 | Nov 08, 2017 (151) |
41 | GNOMAD | ss2747480195 | Nov 08, 2017 (151) |
42 | GNOMAD | ss2831709330 | Nov 08, 2017 (151) |
43 | AFFY | ss2985338255 | Nov 08, 2017 (151) |
44 | AFFY | ss2985969186 | Nov 08, 2017 (151) |
45 | SWEGEN | ss2997921571 | Nov 08, 2017 (151) |
46 | ILLUMINA | ss3022537938 | Nov 08, 2017 (151) |
47 | ILLUMINA | ss3625885381 | Oct 12, 2018 (152) |
48 | ILLUMINA | ss3629359923 | Oct 12, 2018 (152) |
49 | ILLUMINA | ss3632273417 | Oct 12, 2018 (152) |
50 | ILLUMINA | ss3638585558 | Oct 12, 2018 (152) |
51 | ILLUMINA | ss3643529206 | Oct 12, 2018 (152) |
52 | ILLUMINA | ss3644891042 | Oct 12, 2018 (152) |
53 | ILLUMINA | ss3653040791 | Oct 12, 2018 (152) |
54 | ILLUMINA | ss3654110425 | Oct 12, 2018 (152) |
55 | EGCUT_WGS | ss3665838790 | Jul 13, 2019 (153) |
56 | EVA_DECODE | ss3715857525 | Jul 13, 2019 (153) |
57 | ILLUMINA | ss3726277909 | Jul 13, 2019 (153) |
58 | ACPOP | ss3732884471 | Jul 13, 2019 (153) |
59 | ILLUMINA | ss3744260965 | Jul 13, 2019 (153) |
60 | PAGE_CC | ss3771236955 | Jul 13, 2019 (153) |
61 | KHV_HUMAN_GENOMES | ss3807328980 | Jul 13, 2019 (153) |
62 | EVA | ss3824125298 | Apr 26, 2020 (154) |
63 | EVA | ss3825682398 | Apr 26, 2020 (154) |
64 | SGDP_PRJ | ss3863139384 | Apr 26, 2020 (154) |
65 | KRGDB | ss3909805776 | Apr 26, 2020 (154) |
66 | EVA | ss3986322961 | Apr 26, 2021 (155) |
67 | TOPMED | ss4681565076 | Apr 26, 2021 (155) |
68 | EVA | ss5237644442 | Oct 17, 2022 (156) |
69 | 1000G_HIGH_COVERAGE | ss5266125659 | Oct 17, 2022 (156) |
70 | EVA | ss5361483396 | Oct 17, 2022 (156) |
71 | HUGCELL_USP | ss5464062671 | Oct 17, 2022 (156) |
72 | 1000G_HIGH_COVERAGE | ss5550919594 | Oct 17, 2022 (156) |
73 | SANFORD_IMAGENETICS | ss5639039004 | Oct 17, 2022 (156) |
74 | EVA | ss5835752198 | Oct 17, 2022 (156) |
75 | EVA | ss5848067903 | Oct 17, 2022 (156) |
76 | EVA | ss5848637068 | Oct 17, 2022 (156) |
77 | EVA | ss5896649935 | Oct 17, 2022 (156) |
78 | EVA | ss5967515285 | Oct 17, 2022 (156) |
79 | EVA | ss5979757116 | Oct 17, 2022 (156) |
80 | 1000Genomes | NC_000005.9 - 142780339 | Oct 12, 2018 (152) |
81 | 1000Genomes_30x | NC_000005.10 - 143400774 | Oct 17, 2022 (156) |
82 | The Avon Longitudinal Study of Parents and Children | NC_000005.9 - 142780339 | Oct 12, 2018 (152) |
83 | Genome-wide autozygosity in Daghestan | NC_000005.8 - 142760532 | Apr 26, 2020 (154) |
84 | Genetic variation in the Estonian population | NC_000005.9 - 142780339 | Oct 12, 2018 (152) |
85 | ExAC | NC_000005.9 - 142780339 | Oct 12, 2018 (152) |
86 | FINRISK | NC_000005.9 - 142780339 | Apr 26, 2020 (154) |
87 | The Danish reference pan genome | NC_000005.9 - 142780339 | Apr 26, 2020 (154) |
88 | gnomAD - Genomes | NC_000005.10 - 143400774 | Apr 26, 2021 (155) |
89 |
gnomAD - Exomes
Submission ignored due to conflicting rows: |
- | Jul 13, 2019 (153) |
90 |
gnomAD - Exomes
Submission ignored due to conflicting rows: |
- | Jul 13, 2019 (153) |
91 | GO Exome Sequencing Project | NC_000005.9 - 142780339 | Oct 12, 2018 (152) |
92 | Genome of the Netherlands Release 5 | NC_000005.9 - 142780339 | Apr 26, 2020 (154) |
93 | KOREAN population from KRGDB | NC_000005.9 - 142780339 | Apr 26, 2020 (154) |
94 | Medical Genome Project healthy controls from Spanish population | NC_000005.9 - 142780339 | Apr 26, 2020 (154) |
95 | Northern Sweden | NC_000005.9 - 142780339 | Jul 13, 2019 (153) |
96 | The PAGE Study | NC_000005.10 - 143400774 | Jul 13, 2019 (153) |
97 | PharmGKB Aggregated | NC_000005.10 - 143400774 | Apr 26, 2020 (154) |
98 | SGDP_PRJ | NC_000005.9 - 142780339 | Apr 26, 2020 (154) |
99 | Siberian | NC_000005.9 - 142780339 | Apr 26, 2020 (154) |
100 | TopMed | NC_000005.10 - 143400774 | Apr 26, 2021 (155) |
101 | UK 10K study - Twins | NC_000005.9 - 142780339 | Oct 12, 2018 (152) |
102 | ALFA | NC_000005.10 - 143400774 | Apr 26, 2021 (155) |
103 | ClinVar | RCV000017536.30 | Oct 12, 2018 (152) |
104 | ClinVar | RCV000360936.4 | Oct 17, 2022 (156) |
105 | ClinVar | RCV002055861.3 | Oct 17, 2022 (156) |
History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).
Submission IDs | Observation SPDI | Canonical SPDI | Source RSIDs |
---|---|---|---|
ss2735324419 | NC_000005.9:142780338:C:A | NC_000005.10:143400773:C:A | (self) |
404552, ss109472596, ss484950594, ss491875137, ss1397429719, ss1591735738, ss3643529206 | NC_000005.8:142760531:C:T | NC_000005.10:143400773:C:T | (self) |
29229283, 16261491, 11577038, 8026979, 38128, 7545927, 583392, 7222327, 16983170, 216728, 6169336, 15156364, 4011211, 16261491, ss233177998, ss342192853, ss483735877, ss490912774, ss535936231, ss779515274, ss782311487, ss834985687, ss982205738, ss1317539291, ss1581380988, ss1584041667, ss1614185168, ss1657179201, ss1688018862, ss1711100968, ss1946158045, ss1958830249, ss1970224803, ss2023336077, ss2151494857, ss2634349964, ss2634349965, ss2711050776, ss2735324419, ss2747480195, ss2831709330, ss2985338255, ss2985969186, ss2997921571, ss3022537938, ss3625885381, ss3629359923, ss3632273417, ss3638585558, ss3644891042, ss3653040791, ss3654110425, ss3665838790, ss3732884471, ss3744260965, ss3824125298, ss3825682398, ss3863139384, ss3909805776, ss3986322961, ss5361483396, ss5639039004, ss5835752198, ss5848067903, ss5848637068, ss5967515285, ss5979757116 | NC_000005.9:142780338:C:T | NC_000005.10:143400773:C:T | (self) |
RCV000017536.30, RCV000360936.4, RCV002055861.3, 38445529, 206770727, 458424, 10425, 518942633, 1658586229, ss1505810956, ss2278834823, ss3715857525, ss3726277909, ss3771236955, ss3807328980, ss4681565076, ss5237644442, ss5266125659, ss5464062671, ss5550919594, ss5896649935 | NC_000005.10:143400773:C:T | NC_000005.10:143400773:C:T | (self) |
ss7811, ss14865728, ss75137989, ss86211774, ss102664198, ss105110606, ss119337796, ss173989801 | NT_029289.11:3943265:C:T | NC_000005.10:143400773:C:T | (self) |
Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.
PMID | Title | Author | Year | Journal |
---|---|---|---|---|
9150737 | Lack of association between five polymorphisms in the human glucocorticoid receptor gene and glucocorticoid resistance. | Koper JW et al. | 1997 | Human genetics |
12351458 | A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels. | van Rossum EF et al. | 2002 | Diabetes |
15276593 | Association of the ER22/23EK polymorphism in the glucocorticoid receptor gene with survival and C-reactive protein levels in elderly men. | van Rossum EF et al. | 2004 | The American journal of medicine |
15292341 | The ER22/23EK polymorphism in the glucocorticoid receptor gene is associated with a beneficial body composition and muscle strength in young adults. | van Rossum EF et al. | 2004 | The Journal of clinical endocrinology and metabolism |
16030164 | Two polymorphisms in the glucocorticoid receptor gene directly affect glucocorticoid-regulated gene expression. | Russcher H et al. | 2005 | The Journal of clinical endocrinology and metabolism |
17848410 | The 23K variant of the R23K polymorphism in the glucocorticoid receptor gene protects against postnatal growth failure and insulin resistance after preterm birth. | Finken MJ et al. | 2007 | The Journal of clinical endocrinology and metabolism |
19673019 | IL-10 and TNF-alpha promoter haplotypes are associated with childhood Crohn's disease location. | Sanchez R et al. | 2009 | World journal of gastroenterology |
20440229 | Glucocorticoid receptor gene polymorphisms in Italian patients with eating disorders and obesity. | Cellini E et al. | 2010 | Psychiatric genetics |
20547006 | FKBP5 and resistant attachment predict cortisol reactivity in infants: gene-environment interaction. | Luijk MP et al. | 2010 | Psychoneuroendocrinology |
20549395 | Genetics of post-traumatic stress disorder: review and recommendations for genome-wide association studies. | Cornelis MC et al. | 2010 | Current psychiatry reports |
20712049 | Glucocorticoid receptor gene haplotype structure and steroid therapy outcome in IBD patients. | Mwinyi J et al. | 2010 | World journal of gastroenterology |
21164266 | Glucocorticoid resistance. | van Rossum EFC et al. | 2011 | Endocrine development |
21225419 | Gene-environment interactions: early life stress and risk for depressive and anxiety disorders. | Nugent NR et al. | 2011 | Psychopharmacology |
21448414 | Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease. | De Iudicibus S et al. | 2011 | World journal of gastroenterology |
22427805 | Glucocorticoid receptor 1B and 1C mRNA transcript alterations in schizophrenia and bipolar disorder, and their possible regulation by GR gene variants. | Sinclair D et al. | 2012 | PloS one |
22445700 | The impact of drug metabolizing enzyme polymorphisms on outcomes after antenatal corticosteroid use. | Haas DM et al. | 2012 | American journal of obstetrics and gynecology |
22507373 | Glucocorticoid receptor gene polymorphisms are associated with reduced first-phase glucose-stimulated insulin secretion and disposition index in women, but not in men. | van Raalte DH et al. | 2012 | Diabetic medicine |
22781842 | Variation in the glucocorticoid receptor gene at rs41423247 moderates the effect of prenatal maternal psychological symptoms on child cortisol reactivity and behavior. | Velders FP et al. | 2012 | Neuropsychopharmacology |
23055001 | Genetic evidence for the association of the hypothalamic-pituitary-adrenal (HPA) axis with ADHD and methylphenidate treatment response. | Fortier MÈ et al. | 2013 | Neuromolecular medicine |
24497894 | A Conceptual Model of Psychoneurological Symptom Cluster Variation in Women with Breast Cancer: Bringing Nursing Research to Personalized Medicine. | Starkweather AR et al. | 2013 | Current pharmacogenomics and personalized medicine |
25644744 | Single nucleotide polymorphisms in non-coding region of the glucocorticoid receptor gene and prednisone response in childhood acute lymphoblastic leukemia. | Xue L et al. | 2015 | Leukemia & lymphoma |
25724472 | Polymorphisms in the glucocorticoid receptor gene and in the glucocorticoid-induced transcript 1 gene are associated with disease activity and response to glucocorticoid bridging therapy in rheumatoid arthritis. | Quax RA et al. | 2015 | Rheumatology international |
25741362 | Use of pharmacogenomics in pediatric renal transplant recipients. | Medeiros M et al. | 2015 | Frontiers in genetics |
26518448 | Case-control study of glucocorticoid receptor and corticotrophin-releasing hormone receptor gene variants and risk of perinatal depression. | Tan EC et al. | 2015 | BMC pregnancy and childbirth |
26821164 | Glucocorticoid Receptor (NR3C1) Variants Associate with the Muscle Strength and Size Response to Resistance Training. | Ash GI et al. | 2016 | PloS one |
26823689 | The cardiovascular and hypothalamus-pituitary-adrenal axis response to stress is controlled by glucocorticoid receptor sequence variants and promoter methylation. | Li-Tempel T et al. | 2016 | Clinical epigenetics |
26873309 | Glucocorticoid receptor polymorphisms modulate cardiometabolic risk factors in patients in long-term remission of Cushing's syndrome. | Roerink SH et al. | 2016 | Endocrine |
27081784 | A novel approach to understanding the role of polymorphic forms of the NR3C1 and TGF-β1 genes in the modulation of the expression of IL-5 and IL-15 mRNA in asthmatic inflammation. | Panek M et al. | 2016 | Molecular medicine reports |
27507764 | HPA axis dysregulation, NR3C1 polymorphisms and glucocorticoid receptor isoforms imbalance in metabolic syndrome. | Martins CS et al. | 2017 | Diabetes/metabolism research and reviews |
27528460 | HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition. | Keller J et al. | 2017 | Molecular psychiatry |
28364727 | Hypothalamic-pituitary-adrenal axis genetic variation and early stress moderates amygdala function. | Di Iorio CR et al. | 2017 | Psychoneuroendocrinology |
28641498 | Glucocorticoid Receptor Genetic Variants and Response to Fluoxetine in Major Depressive Disorder. | Nouraei H et al. | 2018 | The Journal of neuropsychiatry and clinical neurosciences |
29100174 | The role of genetic variation in the glucocorticoid receptor (NR3C1) and mineralocorticoid receptor (NR3C2) in the association between cortisol response and cognition under acute stress. | Plieger T et al. | 2018 | Psychoneuroendocrinology |
29526633 | Association between allelic variants of the human glucocorticoid receptor gene and autoimmune diseases: A systematic review and meta-analysis. | Herrera C et al. | 2018 | Autoimmunity reviews |
29761890 | Glucocorticoid receptor gene variants and lower expression of NR3C1 are associated with cocaine use. | Schote AB et al. | 2019 | Addiction biology |
29802709 | Association Between NR3C1 Gene Polymorphisms and Toxicity Induced by Glucocorticoids Therapy in Saudi Children with Acute Lymphoblastic Leukemia. | El-Fayoumi R et al. | 2018 | Asian Pacific journal of cancer prevention |
29879676 | Genetic variation in the glucocorticoid receptor and psychopathology after dexamethasone administration in cardiac surgery patients. | Kok L et al. | 2018 | Journal of psychiatric research |
30210047 | Pharmacogenomic markers of glucocorticoid response in the initial phase of remission induction therapy in childhood acute lymphoblastic leukemia. | Gasic V et al. | 2018 | Radiology and oncology |
30999951 | NR3C1 gene polymorphisms are associated with high-altitude pulmonary edema in Han Chinese. | Yang Y et al. | 2019 | Journal of physiological anthropology |
31022961 | FKBP5 rs4713916: A Potential Genetic Predictor of Interindividual Different Response to Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease in a Real-Life Setting. | Russo P et al. | 2019 | International journal of molecular sciences |
31724909 | Role of NR3C1 and GAS5 genes polymorphisms in multiple sclerosis. | Moradi M et al. | 2020 | The International journal of neuroscience |
32032633 | Dual biomarkers long non-coding RNA GAS5 and its target, NR3C1, contribute to acute myeloid leukemia. | Ketab FNG et al. | 2020 | Experimental and molecular pathology |
33019527 | The Pathways between Cortisol-Related Regulation Genes and PTSD Psychotherapy. | Castro-Vale I et al. | 2020 | Healthcare (Basel, Switzerland) |
33562675 | The Glucocorticoid Receptor Gene (NR3C1) 9β SNP Is Associated with Posttraumatic Stress Disorder. | Castro-Vale I et al. | 2021 | Healthcare (Basel, Switzerland) |
34298075 | Glucocorticoid receptor Gene (NR3C1) Polymorphisms and Haplotypes in patients with congenital adrenal hyperplasia. | Villela TR et al. | 2021 | Molecular and cellular endocrinology |
34466443 | Genetic Variant of Glucocorticoid Receptor Gene at rs41423247 and Its Association with Major Depressive Disorder: A Case-Control Study. | Firouzabadi N et al. | 2018 | Galen medical journal |
34721069 | The Glucocorticoid Receptor Polymorphism Landscape in Patients With Diamond Blackfan Anemia Reveals an Association Between Two Clinically Relevant Single Nucleotide Polymorphisms and Time to Diagnosis. | Lonetti A et al. | 2021 | Frontiers in physiology |
The Flanks tab provides retrieving flanking sequences of a SNP on all molecules that have placements.
Genomic regions, transcripts, and products
Top▲
Help
NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.
NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.